ABVC BioPharma SG&A Expense (Quarterly) Trends

ABVC BioPharma Inc (ABVC)

1.06 -0.02 (-1.85%) USD | NASDAQ | May 16, 16:00

1.07 +0.01 (+0.94%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2004. Upgrade now.

Date	Value
December 31, 2023	1.752M
September 30, 2023	2.000M
June 30, 2023	1.612M
March 31, 2023	1.639M
December 31, 2022	1.961M
September 30, 2022	3.442M
June 30, 2022	1.819M
March 31, 2022	5.883M
December 31, 2021	6.146M
September 30, 2021	1.806M
June 30, 2021	1.707M
March 31, 2021	1.393M
December 31, 2020	4.728M
September 30, 2020	1.262M
June 30, 2020	1.277M
March 31, 2020	1.153M
December 31, 2019	0.9517M
September 30, 2019	1.041M
June 30, 2019	0.5795M
March 31, 2019	0.5194M
December 31, 2018	-0.5128M
September 30, 2018	0.342M
June 30, 2018	0.4686M
March 31, 2018	0.4261M
December 31, 2017	0.3071M

Date	Value
September 30, 2017	0.2763M
June 30, 2017	0.172M
March 31, 2017	0.2117M
December 31, 2016	0.1852M
September 30, 2016	0.6478M
June 30, 2016	0.2891M
March 31, 2016	0.1087M
December 31, 2015	0.0016M
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014
September 30, 2014
June 30, 2014
March 31, 2014
December 31, 2013
September 30, 2013
June 30, 2013
March 31, 2013
December 31, 2012
September 30, 2012
June 30, 2012
March 31, 2012
December 31, 2011
September 30, 2011

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.5795M

Minimum

Jun 2019

6.146M

Maximum

Dec 2021

2.219M

Average

1.707M

Median

Jun 2021

SG&A Expense (Quarterly) Benchmarks